Express Diagnostics News
EDI launches extensive update to website

Express Diagnostics is pleased to announce a significant revision to its website — drugcheck.com. The site now provides information on EDI’s expanded product line, including AlcoCheck™ and HealthCheck™ brands. Also available on the new site is a page dedicated to Customer Support. Questions submitted through the Customer Support page are routed directly to customer service representatives to ensure quick replies.
New CLIA-waived drugs of abuse testing devices

DrugCheck® Waive™ CLIA-waived screens provide fast, accurate, easy-to-read results in minutes. Two dip test formats are available in 12-panel (two-sided) and single-panel screening devices. Our operator-activated cup detects 12 drugs of abuse (OPI 2000 cutoff) and five adulterants (OX, SG, CR, pH, NI).
- CLIA-waived cup and dips
- Waived for up to 12 drugs
- Lab accuracy
- Results in 5 minutes
- FDA 510K cleared
EDI introduces new adulterant configurations
Adulterant (specimen validity) testing
Adulteration results are obtained by direct comparison of the reacted strips with color blocks on the charts included in each box of devices. Testing in 3- or 6-panels is offered in the following adulterants:
- pH
- Specific gravity (SG)
- Oxidants (OX)
- Creatinine (CR)
- Nitrite (NI)
- Glutaraldehyde (GL)
Strips contain pH, SG, OX and CR, NI, GL. The adulterant color chart is now combined with the alcohol color chart in a convenient fold-able card that users can stand up for easy viewing. The back of the card includes alcohol and adulterant testing information.

New Single-Drug Dip Test devices screen for 14 individual drugs or alcohol
Product features and benefits:
- Detection of one of 14 individual drugs or alcohol*
- 100% Made in the U.S.A.
- Window for results
- End cap covers dipped portion of test strip
- Photocopy or scan results
- OMS Ready™
- Results in 5 minutes
*Forensic use only
DrugCheck® Online Management System™ implemented

Drug test administrators can now manage multiple aspects of their onsite drug testing program, including testing procedures, results management, and training with the DrugCheck® Online Management System™ (OMS). As the most powerful tool in the DrugCheck® OMS™, the Results Management section of the web-based software allows users to upload scanned results from NxScan and Dip Test devices, record donor results, and refer back to past records on each drug test entered into the system. Administrators interested in reviewing the DrugCheck® OMS™ can contact their DrugCheck® distributor for more information.
Ready for a quick dip?
In September 2008 Express Diagnostics introduced the next generation of its Dip Drug Test, with a new flood-proof label. The DrugCheck® Dip Drug Test provides simultaneous detection of up to 14 drugs, adulterants and/or alcohol and allows users to photocopy or scan results for a permanent record.
Health Canada License obtained
The government of Canada recently issued Express Diagnostics a license (#77258) authorizing distribution in the country. With licensure under the name DrugCheck® Onsite Multi-Drug Drug of Abuse Test (urine), EDI is now able to market its products throughout Canada. For more information, feel free to contact EDI or visit the Health Canada website.
Copy/scan results for permanent record with
the new NxScan OnSite Drug Test Cup
Express Diagnostics is pleased to announce the next generation of its onsite drug testing cup—the DrugCheck® NxScan OnSite cup:
- Photocopy or scan results for permanent record (template included)
- Cup lies flat on copier or scanner for clear copying or scanning
- Results in 5 minutes
- Lab accuracy
- Simultaneous detection of up to 14 drugs, adulterants and/or alcohol
- One drug per color-coded strip
- Easy interpretation and better sensitivity
For more information, email us at info@drugcheck.com.
ISO 13485:2003
We are pleased to announce our certification with ISO 13485:2003, the international standard for quality in medical devices and services.
As defined by the International Organization for Standardization:
ISO 13485:2003 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer requirements and regulatory requirements applicable to medical devices and related services.
CE Certification
“CE” is an abbreviation for the French: “Conformité Européne.” Inclusion of CE marking indicates conformity with respect to European Union (EU) distribution standards. Certification allows manufacturers to freely distribute products throughout the 27-member EU market of nearly 500 million people.
